A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy Participants

NCT04605718 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: RO7223280

Sponsor

Hoffmann-La Roche